Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial

NCT07321535 is registered in ClinicalTrials.gov with Wangjing Hospital, China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT07321535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07321535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Wangjing Hospital, China Academy of Chinese Medical Sciences
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
December 31, 2026
Enrollment
106 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sarcopenia